George Bondar, DO
Dermatology · Seminole, FLNPI 1902807365
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $373 of the $473 with a category attached, or 78.9%. 10 manufacturers reported payments, led by Johnson & Johnson at 27.7% of the total. Reporting peaked in 2019 at $144 and has fallen 64.0% since, to $52 in 2024. That places this record below the midpoint for dermatology clinicians in FL, where the typical reported total is $2,563.
Across 19 payments — averaging $24.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$131
- AbbVie$95
- Triad Life Sciences Inc.$43
- Novartis$42
- Arcutis Biotherapeutics, Inc.$38
- Organogenesis Inc.$32
- plus $91 from 4 others
What the payments were for
- Food & beverage$37379%
- Education$10021%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 4 | $131 |
| AbbVie | 5 | $95 |
| Triad Life Sciences Inc. | 1 | $43 |
| Novartis | 2 | $42 |
| Arcutis Biotherapeutics, Inc. | 2 | $38 |
| Organogenesis Inc. | 1 | $32 |
| Amgen | 1 | $30 |
| LEO Pharma Inc. | 1 | $27 |
| Dermavant Sciences, Inc. | 1 | $21 |
| Encore Dermatology Inc. | 1 | $13 |
How this compares
$473 in reported general payments places this provider in the 20th percentile of 1,147 dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Sensoready (2 Pens)Secukinumab | 11 | $78,812 |
| Clobetasol Propionate | 30 | $2,284 |
| Metronidazole | 33 | $1,987 |
| Ketoconazole | 109 | $1,816 |
| Mupirocin | 184 | $1,286 |
| Gentamicin Sulfate | 29 | $1,029 |
| Triamcinolone Acetonide | 91 | $1,014 |
| Doxycycline Hyclate | 64 | $733 |
| Betamethasone Dipropionate | 11 | $682 |
| Cephalexin | 133 | $502 |
| Fluocinonide | 13 | $460 |
| Ciclopirox | 19 | $405 |
| ValacyclovirValacyclovir Hcl | 22 | $308 |
| Terbinafine Hcl | 12 | $152 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Seminole
- Francisco KerdelMiami$2.1M
- Brad GlickMargate$2M
- Robert KirsnerMiami$1.4M
- John MinniStuart$1.4M
- Gil YosipovitchMiami$1M
- Shino Bay AguileraFt Lauderdale$1M
- Robert SnyderPembroke Pines$1M
- Marc IngleseTallahassee$989K
- Jeremy GreenCoral Gables$952K
- Mercedes GonzalezMiami$943K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.